Valeant Pharmaceuticals Chief Returns From Medical Leave by ANDREW POLLACK

By ANDREW POLLACK

J. Michael Pearson is returning as chief executive after two months, but is giving up his role as chairman.

Published: February 29, 2016 at 12:00AM

from NYT Business Day http://ift.tt/1QesnnK

from WordPress http://ift.tt/1oRu4yS
via Hadi Aboukhater